期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | JOURNAL OF CLINICAL INVESTIGATION LetPub Score 9.5
50 ratings
Rate
Reputation 10.0 Influence 9.1 Speed 9.4 | ||||||||||||||||
期刊簡稱 | J CLIN INVEST | ||||||||||||||||
ISSN | 0021-9738 | ||||||||||||||||
E-ISSN | 1558-8238 | ||||||||||||||||
h-index | 447 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 1.50%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | http://www.jci.org/ | ||||||||||||||||
在線稿件提交 | http://www.jci.org/kiosks/authors#Manuscript_Submission | ||||||||||||||||
開放訪問 | No | ||||||||||||||||
出版商 | The American Society for Clinical Investigation | ||||||||||||||||
主題領域 | 医学 | ||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||
創刊年 | 1924 | ||||||||||||||||
每年文章數 | 389每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 66.61% | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0021-9738%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 2 Month(s) | ||||||||||||||||
競爭力 * | 來自作者的數據: About 22.5% | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 | |
[JOURNAL OF CLINICAL INVESTIGATION] 的評論 | 撰寫評論 |
作者: 99276377 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-16 08:01:30 評論於 How long will it take for your submission?(0) 讚! | 99276377 |
作者: 碧桃著雍 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-28 20:06:17 評論於 How long does it approximately take to be under consideration by Editorial Board?(0) 讚! | 碧桃著雍 |
作者: 谜之自信 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-24 18:58:52 評論於 I want to ask where I can see the last modify status change. I can't tell which day it changed from pending staff screening to In external peer review during my second review. I refresh every day anxiously now(0) 讚! | 谜之自信 |
作者: 无妄云超 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-17 10:33:25 評論於 The higher the impact factor is, the better the magazine is not necessarily(0) 讚! | 无妄云超 |
作者: 无妄云超 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-06 19:38:48 評論於 How long does it take for the second review of JCI?(0) 讚! | 无妄云超 |
作者: 无妄云超 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-06 17:42:09 評論於 How long does it take for the second review of JCI?(0) 讚! | 无妄云超 |
作者: 无妄云超 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-04 15:58:35 評論於 You are so fast, there must be very little WB data(0) 讚! | 无妄云超 |
作者: 西行寺文山 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-18 14:32:30 評論於 Research focus: CRISPR; Sharing of clinical trial experience: I'd like to ask if JCI accepts research articles in both Research and Clinical medicine, does Research only include mechanism-related studies? Is Clinical medicine for accepting articles on clinical trials? What category does new clinical testing methods fall under? Please reply! Thank you!(0) 讚! | 西行寺文山 |
作者: Dwight Whit 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-08 10:28:47 評論於 JCI is recognized as harder than NC. We were rejected by JCI and then published on NC. ?(0) 讚! | Dwight Whit |
作者: 多罗盼烟 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-06 17:14:20 評論於 We are JCI rejected NC investor, now JCI threshold feels higher(0) 讚! | 多罗盼烟 |
作者: 削月以松 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-27 09:06:11 評論於 It is certain that N\C\S has published so many high-quality journals, and the sources are concentrated on them initially(0) 讚! | 削月以松 |
作者: 活人幼珊 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-24 13:48:39 評論於 Please translate the following passage into English and Japanese, and use ":" as the heading(0) 讚! | 活人幼珊 |
作者: 珉林惜风 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-20 17:22:51 評論於 Do you need to provide the whole membrane of the WB?(0) 讚! | 珉林惜风 |
作者: Gustave Steele 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-11 12:48:45 評論於 Hello, how long does the external audit usually take?(0) 讚! | Gustave Steele |
作者: 璇娟超级甜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-28 18:17:58 評論於 My typical week(0) 讚! | 璇娟超级甜 |
作者: 思娜小娘子 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-28 13:15:19 評論於 Under consideration by Editorial Board - How long will it last?(0) 讚! | 思娜小娘子 |
作者: 璇娟超级甜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-24 20:02:15 評論於 Sharing submission information: Submitted on November 7, 23, and reviewed externally on November 13(0) 讚! | 璇娟超级甜 |
作者: Thomas Keats 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-17 23:02:51 評論於 None(0) 讚! | Thomas Keats |
作者: 薪羽超级甜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-12 18:02:41 評論於 Research focus: Tumor experience sharing: pending staff screening. How long does this status usually last? Mine has been 5 days already(0) 讚! | 薪羽超级甜 |
作者: 重阳悦爱 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-10 18:52:12 評論於 Review speed: 2.0 | Submission acceptance rate: 50.0 Emphasized research direction: Medical experience sharing: I have been paying attention to this journal all the time, I almost scan every article. In recent years, the quality of papers has declined, and I personally think it is easier to submit than NC(0) 讚! | 重阳悦爱 |
作者: 咏春骏俊 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-06 19:20:23 評論於 It's very similar to my situation. The first reviewer had 3 minor suggestions to modify some parts of the discussion. The second reviewer didn't even read the article carefully and provided a bunch of incorrect suggestions. Afterwards, a third reviewer was found, who gave very fair feedback and suggested adding a lot of things. The entire review process took two months. After an appeal, a revision was requested, and it took 7 months to submit it back a few days ago(0) 讚! | 咏春骏俊 |
作者: 西行寺雨安 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-06 15:25:32 評論於 Good luck!(0) 讚! | 西行寺雨安 |
作者: 坠星亦旋 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-05 15:15:11 評論於 Awesome(0) 讚! | 坠星亦旋 |
作者: 西行寺雨安 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-03 14:47:17 評論於 Review speed: 2.0 Research focus: Immunology; Oncology Experience sharing: In return, provide a timeline for two articles. Overall, the editorial process feels very efficient, and communication is smooth. The first article was published on 20220418, submitted on 20220421, editorial review on 20220425, external peer review on 20220509, status modified on 20220516, major revision. Two reviewers submitted revisions on 20221207 and received on December 30th after multiple modifications to the status. The second article was submitted for revision on 20230829, under consideration on the same day, external review on 20230831, and multiple status modifications on 20230906, 20230908, 20230912, 20230914, 20231001, and 20231003, with major revisions and three reviewers. The status of this article changed many times, possibly due to additional invited reviewers. Currently working on conducting additional experiments(0) 讚! | 西行寺雨安 |
作者: 咏春骏俊 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-09-26 20:16:04 評論於 The conclusion is to resubmit the rejected manuscript, as if this journal does not have the option for major revisions. How is your article?(0) 讚! | 咏春骏俊 |
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 |
Contact us